For new biologics and drug development, the quicker a company can get its product to patients, the better. Combining a rapid launch following regulatory approval with effective messaging and post-launch services can provide a competitive advantage.
Gain insights on risk mitigation, the difference between innovator and biosimilar drug product process development, and what to expect from the development and manufacturing partner during the process development phase.
Catalent Biologics is your one integrated partner with the expertise to get your biologics to market faster. We have the passion to help you accelerate, simplify, and de-risk your biologics from development and manufacturing to fill/finish, to clinical supply, and commercial launch.